A polymorphism in the dysbindin gene (DTNBP1) associated with multiple psychiatric disorders including schizophrenia

Behavioral and Brain Functions

Volumn 6, Issue , 2010, Pages

  Voisey, Joanne ^a   Swagell, Christopher D ^a   Hughes, Ian P ^a   Connor, Jason P ^b   Lawford, Bruce R ^a,c   Young, Ross M ^a   Morris, C Phillip ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DYSBINDIN; CARRIER PROTEIN; DTNBP1 PROTEIN, HUMAN;

ADDICTION; ADULT; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OPIATE ADDICTION; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TOBACCO DEPENDENCE; ADOLESCENT; ALLELE; CASE CONTROL STUDY; DNA SEQUENCE; GENETICS; MIDDLE AGED;

ADOLESCENT; ADULT; ALLELES; ANXIETY DISORDERS; BEHAVIOR, ADDICTIVE; CARRIER PROTEINS; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SEQUENCE ANALYSIS, DNA; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 77954324866     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-6-41     Document Type: Article

References (35)

1. Benson MA, Newey SE, Martin-Rendon E, Hawkes R, Blake DJ. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 2001, 276:24232-24241. 10.1074/jbc.M010418200, 11316798.
2. Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F, Arolt V, Blackwood D, Liu X, Sjogren B, Aschauer HN, Hwu HG, Jang K, Livesley WJ, Kennedy JL, Zoega T, Ivarsson O, Bui MT, Yu MH, Havsteen B, Commenges D, Weissenbach J, Schwinger E, Gottesman II, Pakstis AJ, Wetterberg L, Kidd KK. An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet 1995, 11:321-324. 10.1038/ng1195-321, 7581457.
3. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, Wormley B, Sadek H, Kadambi B, Cesare AJ, Gibberman A, Wang X, O'Neill FA, Walsh D, Kendler KS. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002, 71:337-348. 10.1086/341750, 379166, 12098102.
4. Wang S, Sun CE, Walczak CA, Ziegle JS, Kipps BR, Goldin LR, Diehl SR. Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22. Nat Genet 1995, 10:41-46. 10.1038/ng0595-41, 7647789.
5. Duan J, Martinez M, Sanders AR, Hou C, Burrell GJ, Krasner AJ, Schwartz DB, Gejman PV. DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene. Hum Hered 2007, 64:97-106. 10.1159/000101961, 2861529, 17476109.
6. Pae CU, Mandelli L, De Ronchi D, Kim JJ, Jun TY, Patkar AA, Serretti A. Dysbindin gene (DTNBP1) and schizophrenia in Korean population. Eur Arch Psychiatry Clin Neurosci 2009, 259:137-142. 10.1007/s00406-008-0830-y, 19252939.
7. Konradi C, Heckers S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol Ther 2003, 97:153-179. 10.1016/S0163-7258(02)00328-5, 12559388.
8. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 2003, 40:881-884. 10.1016/S0896-6273(03)00757-8, 14659087.
9. Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, Avedisova AS, Bardenstein LM, Gurovich IY, Morozova MA, Mosolov SN, Neznanov NG, Reznik AM, Smulevich AB, Tochilov VA, Johnson BG, Monn JA, Schoepp DD. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med 2007, 13:1102-1107. 10.1038/nm1632, 17767166.
10. Bray NJ, Preece A, Williams NM, Moskvina V, Buckland PR, Owen MJ, O'Donovan MC. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum Mol Genet 2005, 14:1947-1954. 10.1093/hmg/ddi199, 15917270.
11. Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ, Hahn CG, Siegel SJ, Trojanowski JQ, Gur RE, Blake DJ, Arnold SE. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 2004, 113:1353-1363. 398430, 15124027.
12. Weickert CS, Rothmond DA, Hyde TM, Kleinman JE, Straub RE. Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients. Schizophr Res 2008, 98:105-110. 10.1016/j.schres.2007.05.041, 2246024, 17961984.
13. Weickert CS, Straub RE, McClintock BW, Matsumoto M, Hashimoto R, Hyde TM, Herman MM, Weinberger DR, Kleinman JE. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 2004, 61:544-555. 10.1001/archpsyc.61.6.544, 15184234.
14. Tang J, LeGros RP, Louneva N, Yeh L, Cohen JW, Hahn CG, Blake DJ, Arnold SE, Talbot K. Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression. Hum Mol Genet 2009, 18:3851-3863. 10.1093/hmg/ddp329, 19617633.
15. Raybould R, Green EK, MacGregor S, Gordon-Smith K, Heron J, Hyde S, Caesar S, Nikolov I, Williams N, Jones L, O'Donovan MC, Owen MJ, Jones I, Kirov G, Craddock N. Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1). Biol Psychiatry 2005, 57:696-701. 10.1016/j.biopsych.2005.01.018, 15820225.
16. Snyder SH. Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines. Am J Psychiatry 1973, 130:61-67.
17. Ujike H. Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr Psychiatry Rep 2002, 4:177-184. 10.1007/s11920-002-0024-7, 12003679.
18. Kishimoto M, Ujike H, Motohashi Y, Tanaka Y, Okahisa Y, Kotaka T, Harano M, Inada T, Yamada M, Komiyama T, Hori T, Sekine Y, Iwata N, Sora I, Iyo M, Ozaki N, Kuroda S. The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis. Biol Psychiatry 2008, 63:191-196. 10.1016/j.biopsych.2007.03.019, 17555717.
19. Lawford BR, Young RM, Swagell CD, Barnes M, Burton SC, Ward WK, Heslop KR, Shadforth S, van Daal A, Morris CP. The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia. Schizophr Res 2005, 73:31-37. 10.1016/j.schres.2004.08.020, 15567074.
20. Voisey J, Swagell CD, Hughes IP, Morris CP, van Daal A, Noble EP, Kann B, Heslop KA, Young RM, Lawford BR. The DRD2 gene 957C > T polymorphism is associated with posttraumatic stress disorder in war veterans. Depress Anxiety 2009, 26:28-33. 10.1002/da.20517, 18833581.
21. Xu H, Kellendonk CB, Simpson EH, Keilp JG, Bruder GE, Polan HJ, Kandel ER, Gilliam TC. DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability. Schizophr Res 2007, 90:104-107. 10.1016/j.schres.2006.10.001, 17113268.
22. White MJ, Lawford BR, Morris CP, Young RM. Interaction between DRD2 C957T polymorphism and an acute psychosocial stressor on reward-related behavioral impulsivity. Behav Genet 2009, 39:285-295. 10.1007/s10519-008-9255-7, 19148742.
23. Hill SY, Hoffman EK, Zezza N, Thalamuthu A, Weeks DE, Matthews AG, Mukhopadhyay I. Dopaminergic mutations: within-family association and linkage in multiplex alcohol dependence families. Am J Med Genet Part B 2008, 147B:517-526. 10.1002/ajmg.b.30630, 17948902.
24. Voisey J, Swagell CD, Hughes IP, Lawford BR, Young RM, Morris CP. Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia. Eur Psychiatry 2010, doi:10.1016/j.eurpsy.2009.11.011.
25. Achim AM, Maziade M, Raymond E, Olivier D, Merette C, Roy MA. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull 2009, doi:10.1093/schbul/sbp1148.
26. McCreadie RG. Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study. Br J Psychiatry 2002, 181:321-325. 10.1192/bjp.181.4.321, 12356659.
27. Keane TM, Caddell JM, Taylor KL. Mississippi Scale for Combat-Related Posttraumatic Stress Disorder: three studies in reliability and validity. J Consult Clin Psychol 1988, 56:85-90. 10.1037/0022-006X.56.1.85, 3346454.
28. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991, 86:1119-1127. 10.1111/j.1360-0443.1991.tb01879.x, 1932883.
29. Abramson JH. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 2004, 1:6. 10.1186/1742-5573-1-6, 544871, 15606913.
30. Ott J. Utility programs for analysis of genetic linkage, Program, HWE version 1.10. 1988, New York: Columbia University.
31. Vilella E, Costas J, Sanjuan J, Guitart M, De Diego Y, Carracedo A, Martorell L, Valero J, Labad A, De Frutos R, Najera C, Molto MD, Toirac I, Guillamat R, Brunet A, Valles V, Perez L, Leon M, de Fonseca FR, Phillips C, Torres M. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. J Psychiatr Res 2008, 42:278-288. 10.1016/j.jpsychires.2007.02.005, 17408693.
32. Cox MM, Tucker AM, Tang J, Talbot K, Richer DC, Yeh L, Arnold SE. Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background. Genes Brain Behav 2009, 8:390-397. 10.1111/j.1601-183X.2009.00477.x, 2774142, 19220483.
33. Kumamoto N, Matsuzaki S, Inoue K, Hattori T, Shimizu S, Hashimoto R, Yamatodani A, Katayama T, Tohyama M. Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin. Biochem Biophys Res Commun 2006, 345:904-909. 10.1016/j.bbrc.2006.04.163, 16701550.
34. Iizuka Y, Sei Y, Weinberger DR, Straub RE. Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization. J Neurosci 2007, 27:12390-12395. 10.1523/JNEUROSCI.1689-07.2007, 17989303.
35. Duan J, Sanders AR, Gejman PV. Genome-wide approaches to schizophrenia. Brain Res Bull 2010, doi:10.1016/j.brainresbull.2010.04.009.